NCT07373379Not yet recruiting
Blended Resources for Integrated Diabetes Guidance and Empowerment
Effectiveness and Implementation of an AI-Driven Blended Care Model for Type 2 Diabetes Management in Primary Care: A Single-Blind, Cluster Randomized Controlled Trial in Zhangjiagang, China
Source: ClinicalTrials.gov · Last updated 23 Feb 2026
Brief summary (registry, in English)
The goal of this cluster randomized clinical trial is to learn if an AI-enabled blended care model (the BRIDGE program) works to treat type 2 diabetes in adults. It will also learn about the cost-effectiveness and implementation feasibility of this model in primary care settings. The main questions it aims to answer are: Does the AI-driven intervention lower HbA1c levels (blood sugar) compared to standard care? Does this model improve participants' quality of life, self-management behaviors, and digital literacy? Researchers will compare the "Diet-Medicine Companion" (Shi Yi Ban Lv) mini-program combined with family doctor support to standard community care to see if the blended care model works to manage diabetes. Participants will: Use the "Diet-Medicine Companion" mini-program to upload diet photos daily and receive AI feedback for 6 months Receive periodic guidance and phone reminders from case administrators (family doctors) Complete questionnaires and blood tests (HbA1c) at baseline, 3 months, and 6 months
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 1200 (estimated)
- First submitted
- 21 Jan 2026
- Start date
- 1 Mar 2026
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- Peking University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07373379
What you commit to
- Study type: Interventional
- Planned participants: 1200
- From 1 Mar 2026 to the primary completion date, 1 Mar 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received radiotherapy or chemotherapy within the past 6 months.
Other illness
- Diagnosed with Type 1 diabetes, gestational diabetes, or secondary diabetes.
- Diagnosed with severe intellectual disabilities, Alzheimer's disease, or other serious psychiatric disorders.
- Presence of other severe disabilities or medical conditions deemed unsuitable for participation by the investigators.
Other
- Presence of severe diabetic complications.
- Current participation in other research projects that may affect the results of this study.
Who the study is looking for
- Aged 18 to 70 years (inclusive).
- Glycosylated hemoglobin (HbA1c) level ≥ 6.5%.
- Resided in the local area for at least 6 months.
- Capable of using a smartphone to take photos and use the WeChat mini-program.
- Willing and able to provide informed consent.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.